BlackRock
VMD icon

BlackRock’s Viemed Healthcare VMD Stock Holding History

BlackRock’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.6M Buy
4,788,307
+165,745
+4% +$1.64M ﹤0.01% 2626
2026
Q1 		$42.6M Sell
4,622,562
-3,514
-0.1% -$29.2K ﹤0.01% 2611
2025
Q4 		$34.4M Sell
4,626,076
-142,252
-3% -$975K ﹤0.01% 2765
2025
Q3 		$32.4M Sell
4,768,328
-54,992
-1% -$372K ﹤0.01% 2789
2025
Q2 		$33.3M Buy
4,823,320
+1,208,703
+33% +$8.2M ﹤0.01% 2716
2025
Q1 		$26.3M Buy
3,614,617
+525,799
+17% +$4.13M ﹤0.01% 2775
2024
Q4 		$24.8M Buy
3,088,818
+110,690
+4% +$960K ﹤0.01% 2915
2024
Q3 		$21.8M Buy
2,978,128
+65,772
+2% +$470K ﹤0.01% 2988
2024
Q2 		$19.1M Buy
2,912,356
+342,520
+13% +$2.58M ﹤0.01% 3010
2024
Q1 		$24.2M Buy
2,569,836
+440,761
+21% +$3.78M ﹤0.01% 2884
2023
Q4 		$16.7M Buy
2,129,075
+143,490
+7% +$1.04M ﹤0.01% 3109
2023
Q3 		$13.4M Buy
1,985,585
+71,921
+4% +$589K ﹤0.01% 3155
2023
Q2 		$18.7M Buy
1,913,664
+1,428,667
+295% +$14.5M ﹤0.01% 3085
2023
Q1 		$4.69M Sell
484,997
-57,154
-11% -$498K ﹤0.01% 3662
2022
Q4 		$4.1M Sell
542,151
-3,120
-0.6% -$21.1K ﹤0.01% 3817
2022
Q3 		$3.27M Sell
545,271
-381,635
-41% -$2.45M ﹤0.01% 3943
2022
Q2 		$4.99M Sell
926,906
-1,313,665
-59% -$7.08M ﹤0.01% 3817
2022
Q1 		$11.2M Buy
2,240,571
+26,045
+1% +$121K ﹤0.01% 3517
2021
Q4 		$11.6M Buy
2,214,526
+7,067
+0.3% +$39.4K ﹤0.01% 3592
2021
Q3 		$12.3M Sell
2,207,459
-11,230
-0.5% -$73.1K ﹤0.01% 3582
2021
Q2 		$15.9M Buy
2,218,689
+5,475
+0.2% +$47.4K ﹤0.01% 3430
2021
Q1 		$22.4M Sell
2,213,214
-41,017
-2% -$386K ﹤0.01% 3127
2020
Q4 		$17.5M Buy
2,254,231
+50,959
+2% +$448K ﹤0.01% 3078
2020
Q3 		$19M Buy
2,203,272
+401,037
+22% +$4.05M ﹤0.01% 2881
2020
Q2 		$17.3M Buy
1,802,235
+1,795,417
+26,333% +$14M ﹤0.01% 2869
2020
Q1 		$32K Buy
+6,818
New +$33.8K ﹤0.01% 4548

Other funds holding VMD

FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock's VMD Position: Q2 2026 in Review

BlackRock increased its Viemed Healthcare (VMD) stake by 3.6% in Q2 2026, buying an estimated $1.64M and bringing the position to 4,788,307 shares worth $54.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

BlackRock first reported a position in VMD in Q1 2020 and has held it in 26 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • BlackRock held 4,788,307 shares of Viemed Healthcare worth $54.6M as of Q2 2026.
  • BlackRock bought 165,745 Viemed Healthcare shares in Q2 2026, an estimated $1.64M.
  • Viemed Healthcare made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2626 holding.
  • BlackRock first reported a position in Viemed Healthcare in Q1 2020 and has held it in 26 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.